Advocacy, policies and practicalities of preventive chemotherapy campaigns for African children with schistosomiasis

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 7, 2013, Pages 733-752

  Stothard, J Russell ^a   Sousa Figueiredo, José C ^a,b   Navaratnam, Annalan M D ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cure rate; egg reduction rate; intestinal schistosomiasis; praziquantel; preventive chemotherapy; Schistosoma; urogenital schistosomiasis

Indexed keywords

PRAZIQUANTEL;

AFRICAN; CHILD; CHILD HEALTH CARE; DISEASE MARKER; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; DRUG TREATMENT FAILURE; ETHNIC GROUP; GEOGRAPHIC DISTRIBUTION; GEOGRAPHIC MAPPING; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTERPERSONAL COMMUNICATION; INTESTINE INFECTION; NONHUMAN; PATIENT ADVOCACY; PATIENT MONITORING; POLITICAL PARTICIPATION; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; RISK ASSESSMENT; SCHISTOSOMA; SCHISTOSOMA BOVIS; SCHISTOSOMA CURASSONI; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL HEALTH SERVICE; SYSTEMATIC REVIEW (TOPIC); UROGENITAL TRACT INFECTION; VOMITING;

EID: 84880906829     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2013.811931     Document Type: Review

References (131)

1. King CH. Parasites and poverty: The case of schistosomiasis. Acta Trop. 113(2), 95-104 (2010
2. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2(7), 499-511 (2002
3. Stothard Jr. Improving control of African schistosomiasis: Towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans. R. Soc. Trop. Med. Hyg. 103(4), 325-332 (2009
4. WHO. SCHISTOSOMIASIS progress report 2001-2011 Strategic Plan 2012-2020. WHO, Geneva, Switzerland (2012
5. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: Systematic review, meta-Analysis, and estimates of people at risk. Lancet Infect. Dis. 6(7), 411-425 (2006
6. Stothard JR, Gabrielli AF Schistosomiasis in African infants and preschool children: To treat or not to treat? Trends Parasitol. 23(3), 83-86 (2007
7. Brooker S, Kabatereine NB, Gyapong JO, Stothard JR, Utzinger J. Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. Parasitology 136(13), 1707-1718 (2009
8. Emery AM, Allan FE, Rabone ME, Rollinson D. Schistosomiasis collection at NHM (SCAN). Parasit. Vectors 5, 185 (2012
9. Rollinson D, Webster JP, Webster B, Nyakaana S, Jørgensen A, Stothard Jr. Genetic diversity of schistosomes and snails: Implications for control. Parasitology 136(13), 1801-1811 (2009
10. Standley CJ, Mugisha L, Dobson AP, Stothard Jr. Zoonotic schistosomiasis in non-human primates: Past, present and future activities at the human-wildlife interface in Africa. J. Helminthol. 86(2), 131-140 (2012
11. Huyse T, Webster BL, Geldof S et al. Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog. 5(9), e1000571 (2009
12. Webster BL, Rollinson D, Stothard JR, Huyse T. Rapid diagnostic multiplex PCR (RD-PCR) to discriminate Schistosoma haematobium and S. bovis. J. Helminthol. 84(1), 107-114 (2010
13. Stothard JR, Sousa-Figueiredo JC, Betson M et al. Closing the praziquantel treatment gap: New steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-Aged children. Parasitology 138(12), 1593-1606 (2011
14. WHO. Helminth control in school-Age children: A guide for control programmes 2nd edition. (2011
15. Montresor A, Gabrielli AF, Chitsulo L et al. Preventive chemotherapy and the fight against neglected tropical diseases. Expert Rev. Anti. Infect. Ther. 10(2), 237-242 (2012
16. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: Mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 21(6), 659-667 (2008
17. Hotez PJ, Molyneux DH, Fenwick A et al. Control of neglected tropical diseases. N. Engl. J. Med. 357(10), 1018-1027 (2007
18. King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: A systematic review. PLoS Negl. Trop. Dis. 5(9), e1321 (2011
19. Fenwick A, Rollinson D, Southgate V. Implementation of human schistosomiasis control: Challenges and prospects. In: Advances in Parasitology, Vol 61: Control of Human Parasitic Diseases. (2006
20. Hotez PJ, Engels D, Fenwick A, Savioli L. Africa is desperate for praziquantel. Lancet 376(9740), 496-498 (2010
21. Hotez PJ, Fenwick A. Schistosomiasis in Africa: An emerging tragedy in our new global health decade. PLoS Neglect. Trop. Dis. 3(9), e485 (2009
22. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373(9674), 1570-1575 (2009
23. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 3(5), e102 (2006
24. Fleming FM, Fenwick A, Tukahebwa EM et al. Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: Perceptions, attitudes and constraints of a national programme. Parasitology 136(13), 1759-1769 (2009
25. Garba A, Touré; S, Dembelé; R et al. Present and future schistosomiasis control activities with support from the Schistosomiasis Control Initiative in West Africa. Parasitology 136(13), 1731-1737 (2009
26. Brooker S, Kabatereine NB, Fleming F, Devlin N Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: Intra-country variation and effects of scaling-up. Health Policy Plan. 23(1), 24-35 (2008
27. Leslie J, Garba A, Oliva EB et al. Schistosomiasis and soil-Transmitted helminth control in Niger: Cost-effectiveness of school based and community distributed mass drug administration [corrected]. PLoS Negl. Trop. Dis. 5(10), e1326 (2011
28. Savioli L, Gabrielli AF, Montresor A, Chitsulo L, Engels D Schistosomiasis control in Africa: 8 years after World Health Assembly Resolution 54.19. Parasitology 136(13), 1677-1681 (2009
29. Fenwick A. New initiatives against Africa's worms. Trans. R. Soc. Trop. Med. Hyg. 100(3), 200-207 (2006
30. Zhang Y, Koukounari A, Kabatereine N et al. Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-Transmitted helminthiasis in Uganda. BMC Med. 5, 27 (2007
31. Hotez P, Raff S, Fenwick A, Richards F Jr, Molyneux DH. Recent progress in integrated neglected tropical disease control. Trends Parasitol. 23(11), 511-514 (2007
32. Hotez P. A new voice for the poor. Plos Negl. Trop. Dis. 1(1), (2007
33. Allen T, Parker M Will increased funding for neglected tropical diseases really make poverty history? Lancet 379(9821), 1097-1098; author reply 1098 (2012
34. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JC, Blair L. The control of schistosomiasis and soil-Transmitted helminths in East Africa. Trends Parasitol. 22(7), 332-339 (2006
35. Kolaczinski JH, Kabatereine NB, Onapa AW, Ndyomugyenyi R, Kakembo AS, Brooker S. Neglected tropical diseases in Uganda: The prospect and challenge of integrated control. Trends Parasitol. 23(10), 485-493 (2007
36. Tchuente LAT, N'goran EK. Schistosomiasis and soil-Transmitted helminthiasis control in Cameroon and Cote d'Ivoire: Implementing control on a limited budget. Parasitology 136(13), 1739-1745 (2009
37. Kabatereine NB, Malecela M, Lado M, Zaramba S, Amiel O, Kolaczinski JH. How to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan Africa. PLoS Negl. Trop. Dis. 4(6), e755 (2010
38. Kabatereine NB, Standley CJ, Sousa-Figueiredo JC et al. Integrated prevalence mapping of schistosomiasis, soil-Transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda. Parasit. Vectors 4, 232 (2011
39. Standley CJ, Adriko M, Arinaitwe M et al. Epidemiology and control of intestinal schistosomiasis on the Sesse Islands, Uganda: Integrating malacology and parasitology to tailor local treatment recommendations. Parasit. Vectors 3(1), 64 (2010
40. Standley CJ, Adriko M, Besigye F, Kabatereine NB, Stothard RJ. Confirmed local endemicity and putative high transmission of Schistosoma mansoni in the Sesse Islands, Lake Victoria, Uganda. Parasit. Vectors 4, 29 (2011
41. Parker M, Allen T, Pearson G, Peach N, Flynn R, Rees N. Border parasites: Schistosomiasis control among Uganda's fisherfolk. J. Eastern African Studies 6(1), 98-123 (2012
42. Standley CJ, Stothard Jr. Towards defining appropriate strategies for targeted NTD control. Trop. Med. Int. Health 15(6), 772-773 (2010
43. Sturrock HJW, Gething PW, Ashton RA, Kolaczinski JH, Kabatereine NB, Brooker S. Planning schistosomiasis control: Investigation of alternative sampling strategies for Schistosoma mansoni to target mass drug administration of praziquantel in East Africa. Int. Health 3(3), 165-175 (2011
44. Sturrock HJ, Gething PW, Clements AC, Brooker S. Optimal survey designs for targeting chemotherapy against soil-Transmitted helminths: Effect of spatial heterogeneity and cost-efficiency of sampling. Am. J. Trop. Med. Hyg. 82(6), 1079-1087 (2010
45. Clements AC, Bosqué;-Oliva E, Sacko M et al. A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006. PLoS Negl. Trop. Dis. 3(5), e431 (2009
46. Clements ACA, Brooker S, Nyandindi U, Fenwick A, Blair L. Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa. Int. J. Parasitol. 38(3-4), 401-415 (2008
47. Clements AC, Deville MA, Ndayishimiye O, Brooker S, Fenwick A. Spatial co-distribution of neglected tropical diseases in the east African great lakes region: Revisiting the justification for integrated control. Trop. Med. Int. Health 15(2), 198-207 (2010
48. Clements AC, Garba A, Sacko M et al. Mapping the probability of schistosomiasis and associated uncertainty, West Africa. Emerging Infect. Dis. 14(10), 1629-1632 (2008
49. Parker M, Allen T. Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-Transmitted helminths in Uganda. Health Res. Policy Systems 9, 3 (2011
50. Parker M, Allen T, Hastings J. Resisting control of neglected tropical diseases: Dilemmas in the mass treatment of schistosomiasis and soil-Transmitted helminths in north-west Uganda. J. Biosoc. Sci. 40(2), 161-181 (2008
51. Stothard JR, Chitsulo L, Kristensen TK, Utzinger J. Control of schistosomiasis in sub-Saharan Africa: Progress made, new opportunities and remaining challenges. Parasitology 136(13), 1665-1675 (2009
52. Sousa-Figueiredo JC, Betson M, Stothard Jr. Treatment of schistosomiasis in African infants and preschool-Aged children: Downward extension and biometric optimization of the current praziquantel dose pole. Int. Health 4(2), 95-102 (2012
53. Sousa-Figueiredo JC, Day M, Betson M, Kabatereine NB, Stothard Jr. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel. Trans. R. Soc. Trop. Med. Hyg. 104(11), 740-742 (2010
54. Fenwick A, Webster JP, Bosque-Oliva E et al. The Schistosomiasis Control Initiative (SCI): Rationale, development and implementation from 2002-2008. Parasitology 136(13), 1719-1730 (2009
55. Basá;ñd;ez MG, French MD, Walker M, Churcher TS. Paradigm lost: How parasite control may alter pattern and process in human helminthiases. Trends Parasitol. 28(4), 161-171 (2012
56. Brooker S, Whawell S, Kabatereine NB, Fenwick A, Anderson RM. Evaluating the epidemiological impact of national control programmes for helminths. Trends Parasitol. 20(11), 537-545 (2004
57. Webster JP, Koukounari A, Lamberton PH, Stothard JR, Fenwick A. Evaluation and application of potential schistosomeassociated morbidity markers within large-scale mass chemotherapy programmes. Parasitology 136(13), 1789-1799 (2009
58. Balen J, Stothard JR, Kabatereine NB et al. Morbidity due to Schistosoma mansoni: An epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy. Trans. R. Soc. Trop. Med. Hyg. 100(11), 1039-1048 (2006
59. Bustinduy AL, Thomas CL, Fiutem JJ et al. Measuring fitness of Kenyan children with polyparasitic infections using the 20-meter shuttle run test as a morbidity metric. PLoS Negl. Trop. Dis. 5(7), e1213 (2011
60. Sousa-Figueiredo JC, Basá;ñd;ez MG, Khamis IS, Garba A, Rollinson D, Stothard Jr. Measuring morbidity associated with urinary schistosomiasis: Assessing levels of excreted urine albumin and urinary tract pathologies. PLoS Negl. Trop. Dis. 3(10), e526 (2009
61. Stothard JR, Sousa-Figueiredo JC, Simba Khamis I, Garba A, Rollinson D. Urinary schistosomiasis-Associated morbidity in schoolchildren detected with urine albumin-To-creatinine ratio (UACR) reagent strips. J. Pediatr. Urol. 5(4), 287-291 (2009
62. Stoever K, Molyneux D, Hotez P, Fenwick A. HIV/AIDS, schistosomiasis, and girls. Lancet 373(9680), 2025-2026 (2009
63. Kjetland EF, Leutscher PD, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol. 28(2), 58-65 (2012
64. Stothard Jr Female genital schistosomiasis -icebergs of morbidity ahead? Trends Parasitol. 28(5), 174-175 (2012
65. Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J Schistosomiasis in African infants and preschool children: Let them now be treated! Trends Parasitol. 29(4), 197-205 (2013
66. Webster BL, Culverwell CL, Khamis IS, Mohammed KA, Rollinson D, Stothard Jr. DNA barcoding of Schistosoma haematobium on Zanzibar reveals substantial genetic diversity and two major phylogenetic groups. Acta Tropica doi:10.1371/journal. pntd.0001882 (2012) (In Press
67. Webster BL, Webster JP, Gouvras AN et al. DNA 'barcoding' of Schistosoma mansoni across sub-Saharan Africa supports substantial within locality diversity and geographical separation of genotypes. Acta Tropica (2012) (In Press
68. Stothard JR, Ameri H, Khamis IS et al. Parasitological and malacological surveys reveal urogenital schistosomiasis on Mafia Island, Tanzania to be an imported infection. Acta Trop. doi:10.1016/j. actatropica.2012.09.006 (2012) (In Press
69. Schur N, Hürlimann E, Stensgaard AS et al. Spatially explicit Schistosoma infection risk in eastern Africa using Bayesian geostatistical modelling. Acta Trop. doi:10.1016/j.actatropica.2011.10.006 (2011) (Epub ahead of print
70. Gouvras AN, Kariuki C, Koukounari A et al. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya. Acta Trop. doi:10.1016/j.actatropica. 2013.01.001 (2013) (Epub ahead of print
71. Webster BL, Diaw OT, Seye MM et al. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal river basin: Monitoring treatment success and re-infection patterns. Acta Trop. (2012) In Press
72. Mwanga JR, Lwambo NJS. Pre-And post-intervention perceptions and water contact behaviour related to schistosomiasis in north-western Tanzania. Acta Tropica doi:10.1016/j.actatropica.2012.09.017 (2012) (In Press
73. Kane RA, Stothard JR, Rollinson D et al. Detection and quantification of schistosome DNA in freshwater snails using either fluorescent probes in real-Time PCR or oligochromatographic dipstick assays targeting the ribosomal intergenic spacer. Acta Trop. doi:10.1016/j.actatropica. 2011.10.019 (2011) (Epub ahead of print
74. Colley DG, Secor WE. A schistosomiasis research agenda. PLoS Negl. Trop. Dis. 1(3), e32 (2007
75. King C, Colley D, Binder S, Campbell C. A progress report from score, the schistosomiasis consortium for operational research and evaluation. Trop. Med. Int. Health 16, 330 (2011
76. Rollinson D, Knopp S, Levitz S et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. doi:10.1016/j. actatropica.2012.04.013 (2012) (Epub ahead of print
77. Knopp S, Stothard JR, Rollinson D et al. From morbidity control to transmission control: Time to change tactics against helminths on Unguja Island, Zanzibar. Acta Tropica doi:10.1016/j.actatropica. 2011.04.010 (2011) (In Press
78. Knopp S, Mohammed KA, Ali SM et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health 12, 930 (2012
79. King CH, Bertino AM. Asymmetries of poverty: Why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl. Trop. Dis. 2(3), e209 (2008
80. Doenhoff MJ, Pica-Mattoccia L. Praziquantel for the treatment of schistosomiasis: Its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev. Anti. Infect. Ther. 4(2), 199-210 (2006
81. Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH. Drugs for the control of parasitic diseases: Current status and development in schistosomiasis. Trends Parasitol. 19(11), 509-515 (2003
82. Cioli D, Valle C, Angelucci F, Miele AE Will new antischistosomal drugs finally emerge? Trends Parasitol. 24(9), 379-382 (2008
83. Cioli D, Basso A, Valle C, Pica-Mattoccia L. Decades down the line: The viability of praziquantel for future schistosomiasis treatment. Expert Rev. Anti. Infect. Ther. 10(8), 835-837 (2012
84. Doenhoff MJ, Modha J, Lambertucci JR, McLaren DJ. The immune dependence of chemotherapy. Parasitol. Today (Regul. Ed.)7(1), 16-18 (1991
85. Olliaro PL, Vaillant MT, Belizario VJ et al. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl. Trop. Dis. 5(6), e1165 (2011
86. Melman SD, Steinauer ML, Cunningham C et al. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl. Trop. Dis. 3(8), e504 (2009
87. Garba A, Lamine MS, Barkiré; N et al. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-Aged children in Niger. Acta Trop. doi:10.1016/j.actatropica.2012.08.008 (2012) (In Press
88. Wegner DH. The profile of the trematodicidal compound praziquantel. Arzneimittelforschung. 34(9B), 1132-1136 (1984
89. Lamberton PH, Hogan SC, Kabatereine NB, Fenwick A, Webster JP. In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections. Am. J. Trop. Med. Hyg. 83(6), 1340-1347 (2010
90. Doenhoff MJ, Hagan P, Cioli D et al. Praziquantel: Its use in control of schistosomiasis in sub-Saharan Africa and current research needs. Parasitology 136(13), 1825-1835 (2009
91. Sulaiman SM, Traoré; M, Engels D, Hagan P, Cioli D. Counterfeit praziquantel. Lancet 358(9282), 666-667 (2001
92. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse ME. A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol. 19(6), 255-263 (1997
93. Augusto G, Magnussen P, Kristensen TK, Appleton CC, Vennervald BJ. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique. Parasitology 136(13), 1771-1779 (2009
94. Abu-Elyazeed RR, Mansour NS, Youssef FG et al. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: Lessons from the practice. J. Egypt. Soc. Parasitol. 28(1), 1-7 (1998
95. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop. Med. Int. Health 5(11), 771-778 (2000
96. Raso G, N'Goran EK, Toty A et al. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans. R. Soc. Trop. Med. Hyg. 98(1), 18-27 (2004
97. De Clercq D, Vercruysse J, Kongs A, Verlé; P, Dompnier JP, Faye PC. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 82(1), 61-66 (2002
98. Mohamed AA, Mahgoub HM, Magzoub M et al. Artesunate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Trans. R. Soc. Trop. Med. Hyg. 103(10), 1062-1064 (2009
99. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse ME. Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children. Parasite Immunol. 20(12), 595-600 (1998
100. Sousa-Figueiredo JC, Pleasant J, Day M et al. Treatment of intestinal schistosomiasis in Ugandan preschool children: Best diagnosis, treatment efficacy and sideeffects, and an extended praziquantel dosing pole. Int. Health 2(2), 103-113 (2010
101. Adoubryn KD, Kouadio-Yapo CG, Ouhon J, Aka NA, Bintto F, Assoumou A. Intestinal parasites in children in Biankouma, Ivory Coast (mountaineous western region): Efficacy and safety of praziquantel and albendazole. Med. Sante. Trop. 22(2), 170-176 (2012
102. Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele elementary school, Wondo Genet, Southern Ethiopia. Asian Pacific J. Trop. Biomed. 235-239 (2012
103. Borrmann S, Szlezá;k N, Faucher JF et al. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: A double-blind, randomized, placebo-controlled study. J. Infect. Dis. 184(10), 1363-1366 (2001
104. Coulibaly JT, N'gbesso YK, Knopp S, Keiser J, N'Goran EK, Utzinger J. Efficacy and safety of praziquantel in preschool-Aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLoS Negl. Trop. Dis. 6(12), e1917 (2012
105. Degu G, Mengistu G, Jones J. Praziquantel efficacy against schistosomiasis mansoni in schoolchildren in north-west Ethiopia. Trans. R. Soc. Trop. Med. Hyg. 96(4), 444-445 (2002
106. Garba A, Lamine MS, Djibo A et al. Safety and efficacy of praziquantel syrup (Epiquantel(®)) against Schistosoma haematobium and Schistosoma mansoni in preschool-Aged children in Niger. Acta Trop. doi:10.1016/j. actatropica. 2012.12.003 (2012) (Epub ahead of print
107. Garba A, Tohon Z, Sidiki A, Chippaux JP, de Chabalier F. [Efficacity of praziquantel in school-Aged children in a hyperendemic zone for Schistoma haematobium (Niger, 1999)]. Bull. Soc. Pathol. Exot. 94(1), 42-45 (2001
108. Guyatt HL, Brooker S, Kihamia CM, Hall A, Bundy DA. Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull. World Health Organ. 79(8), 695-703 (2001
109. Inyang-Etoh PC, Ejezie GC, Useh MF, Inyang-Etoh EC. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 103(1), 38-44 (2009
110. Kahama AI, Vennervald BJ, Kombe Y et al. Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the coast province of Kenya. Trop. Med. Int. Health 4(5), 335-340 (1999
111. Kahama AI, Odek AE, Kihara RW et al. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya. Am. J. Trop. Med. Hyg. 61(2), 215-219 (1999
112. Kardaman MW, Fenwick A, el Igail AB, el Tayeb M, Daffalla AA, Dixon HG. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan. J. Trop. Med. Hyg. 88(2), 105-109 (1985
113. Keiser J, N'Guessan NA, Adoubryn KD et al. Efficacy and safety of mefloquine, artesunate, mefloquine-Artesunate, and praziquantel against Schistosoma haematobium: Randomized, exploratory open-label trial. Clin. Infect. Dis. 50(9), 1205-1213 (2010
114. Kihara JH, Njagi EN, Kenya EU et al. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment. Trans. R. Soc. Trop. Med. Hyg. 103(10), 1024-1030 (2009
115. Kihara JH, Muhoho N, Njomo D et al. Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya. Acta Trop. 102(3), 165-171 (2007
116. King CH, Muchiri EM, Mungai P et al. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 66(6), 725-730 (2002
117. Lwambo NJ, Savioli L, Kisumku UM, Alawi KS, Bundy DA. The relationship between prevalence of Schistosoma haematobium infection and different morbidity indicators during the course of a control programme on Pemba Island. Trans. R. Soc. Trop. Med. Hyg. 91(6), 643-646 (1997
118. McMahon JE, Kolstrup N. Praziquantel: A new schistosomicide against Schistosoma haematobium. Br. Med. J. 2(6202), 1396-1399 (1979
119. Midzi N, Sangweme D, Zinyowera S et al. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans. R. Soc. Trop. Med. Hyg. 102(8), 759-766 (2008
120. Mohammed EH, Eltayeb M, Ibrahim H. Haematological and biochemical morbidity of Schistosoma haematobium in school children in Sudan. Sultan Qaboos Univ. Med. J. 6(2), 59-64 (2006
121. Mutapi F, Rujeni N, Bourke C et al. Schistosoma haematobium treatment in 1-5 year old children: Safety and efficacy of the antihelminthic drug praziquantel. PLoS Negl. Trop. Dis. 5(5), e1143 (2011
122. Navaratnam AM, Sousa-Figueiredo JC, Stothard JR, Kabatereine NB, Fenwick A, Mutumba-Nakalembe MJ. Efficacy of praziquantel syrup versus crushed praziquantel tablets in the treatment of intestinal schistosomiasis in Ugandan preschool children, with observation on compliance and safety. Trans. R. Soc. Trop. Med. Hyg. 106(7), 400-407 (2012
123. Obonyo CO, Muok EM, Mwinzi PN. Efficacy of artesunate with sulfalene plus pyrimethamine versus praziquantel for treatment of Schistosoma mansoni in Kenyan children: An open-label randomised controlled trial. Lancet Infect. Dis. 10(9), 603-611 (2010
124. Olds GR, King C, Hewlett J et al. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J. Infect. Dis. 179(4), 996-1003 (1999
125. Pugh RN, Teesdale CH. Single dose oral treatment in urinary schistosomiasis: A double blind trial. Br. Med. J. (Clin. Res. Ed). 286(6363), 429-432 (1983
126. Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa. BMC Infect. Dis. 4, 40 (2004
127. Sacko M, Magnussen P, Traoré; M et al. The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-Aged children in Mali. Parasitology 136(13), 1851-1857 (2009
128. Scherrer AU, Sjöberg MK, Allangba A et al. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration. Acta Trop. 109(3), 226-231 (2009
129. Sissoko MS, Dabo A, Traoré; H et al. Efficacy of artesunate + sulfamethoxypyrazine/ pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS ONE 4(10), e6732 (2009
130. Sousa-Figueiredo JC, Betson M, Atuhaire A et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl. Trop. Dis. 6(10), e1864 (2012
131. Stete K, Krauth SJ, Coulibaly JT et al. Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-Aged children. Parasit. Vectors 5, 298 (2012